
1. curr opin chem biol. 2014 feb;18:87-94. doi: 10.1016/j.cbpa.2014.01.007. epub
2014 feb 7.

the neoglycolipid (ngl)-based oligosaccharide microarray system poised to
decipher meta-glycome.

palma as(1), feizi t(2), childs ra(3), chai w(3), liu y(4).

author information: 
(1)the glycosciences laboratory, department medicine, imperial college london,
united kingdom; requimte/cqfb, faculty science technology, new university 
of lisbon, caparica, portugal. electronic address: angelina.palma@fct.unl.pt.
(2)the glycosciences laboratory, department medicine, imperial college london,
united kingdom. electronic address: t.feizi@imperial.ac.uk.
(3)the glycosciences laboratory, department medicine, imperial college london,
united kingdom.
(4)the glycosciences laboratory, department medicine, imperial college london,
united kingdom. electronic address: yan.liu2@imperial.ac.uk.

erratum in
    curr opin chem biol. 2014 aug;21:170.

the neoglycolipid (ngl) technology basis state-of-the-art
oligosaccharide microarray system. ngl-based microarray system the
glycosciences laboratory imperial college london
(http://www3.imperial.ac.uk/glycosciences) one two leading platforms
for glycan microarrays, offered screening analyses broad
biomedical community. highlighted review sensitivity the
analysis system and, coupled mass spectrometry, provision generating
'designer' microarrays glycomes identify novel ligands biological
relevance. among recent applications assignments ligands apicomplexan 
parasites, pandemic 2009 influenza virus, polyoma reoviruses, innate
immune receptor fungal pathogens, dectin-1, novel protein the
endoplasmic reticulum, malectin; also characterization elusive
cancer-associated antigen. contemporary advances in
glycolipid-containing arrays microarrays also discussed.

copyright Â© 2014 authors. published elsevier ltd.. rights reserved.

doi: 10.1016/j.cbpa.2014.01.007 
pmcid: pmc4105633
pmid: 24508828  [indexed medline]

